Provenienza dei contatti di primo grado di Frank W. Falkenberg
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
CyTuVax BV
 CyTuVax BV Pharmaceuticals: MajorHealth Technology CyTuVax BV develops vaccinations for cancer treatment. Its vaccination technology includes an adjuvant composed of depot-bound cytokines acting as immune response modifiers. The firm also provides adjuvant technology licensing services. The company was founded by René Vleugels and Frank W. Falkenberg in 2011 and is headquartered in Maastricht, the Netherlands.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Frank W. Falkenberg tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Radboud University Nijmegen | College/University | Doctorate Degree | |
| Maastricht University | College/University | Corporate Officer/Principal | |
| NovoVacs BV | Founder | ||
AdjuTec BV
 AdjuTec BV Pharmaceuticals: MajorHealth Technology AdjuTec BV is a Dutch company that manufactures personalized therapeutic tumor vaccines for pancreatic and liver cancer patients. The company is based in Maastricht, Netherlands. The company was founded in 2017 by René Vleugels. | Pharmaceuticals: Major | Founder |
Statistiche
Distribuzione geografica
| Paesi Bassi | 6 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni
| Founder | 4 |
| President | 1 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| René Vleugels | 6 |
- Borsa valori
- Insiders
- Frank W. Falkenberg
- Connessioni Società
